RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 The ESCAPE Trial: Rapid Endovascular Treatment Leads to Better Outcomes
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 2
SP 9
OP 10
DO 10.1177/1559897715577947
UL http://mdc.sagepub.com/content/15/2/9.abstract
AB ESCAPE was a phase 3, multicenter, prospective, randomized, open-label, controlled trial conducted in patients with acute ischemic stroke. Patients received rapid, modern endovascular treatment plus guideline-based care (intervention) or guideline-based care alone. Patients in the intervention group had greater benefits in mortality, morbidity, and quality of life compared with controls.